Klin Padiatr 2013; 225(07): 383-388
DOI: 10.1055/s-0033-1361105
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Meconium Aspiration Syndrome – a 21-years’ Experience from a Tertiary Care Center and Analysis of Risk Factors for Predicting Disease Severity

Mekoniumaspirationssyndrom – Verlauf über die letzten 21 Jahre und Analyse von Risikofaktoren für eine schwere Verlaufsform
N. Hofer
1   Department of Pediatrics and Adolescent Medicine, Research Unit for Neonatal Infectious Diseases and Epidemiology, Medical University of Graz, Graz, Austria
,
K. Jank
1   Department of Pediatrics and Adolescent Medicine, Research Unit for Neonatal Infectious Diseases and Epidemiology, Medical University of Graz, Graz, Austria
,
E. Resch
1   Department of Pediatrics and Adolescent Medicine, Research Unit for Neonatal Infectious Diseases and Epidemiology, Medical University of Graz, Graz, Austria
,
B. Urlesberger
2   Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Medical University of Graz, Austria
,
F. Reiterer
2   Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Medical University of Graz, Austria
,
B. Resch
1   Department of Pediatrics and Adolescent Medicine, Research Unit for Neonatal Infectious Diseases and Epidemiology, Medical University of Graz, Graz, Austria
2   Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Medical University of Graz, Austria
› Author Affiliations
Further Information

Publication History

Publication Date:
29 November 2013 (online)

Abstract

Background:

Aim of this study was to describe the course of perinatal factors in neonates with meconium aspiration syndrome (MAS) from 1990 to 2010 and to determine risk factors for a severe course of the disease.

Patients:

All neonates with MAS hospitalized in our level III neonatal intensive care unit from 1990 to 2010.

Method:

Retrospective analysis of trends of perinatal factors in neonates with MAS over time and of the association of these factors with severe MAS (need for invasive mechanical ventilation for ≥7 days, or need for high frequency oscillation or need for extracorporeal membrane oxygenation).

Results:

We included 205 neonates with MAS, 55 had severe MAS (27%). MAS incidence and absolute number of MAS cases per year decreased during the observation period (p=0.003 and 0.005, respectively) as well as rates of outborn deliveries (p=0.004), duration of invasive mechanical ventilation (p=0.004), and hospital stay (p=0.036). Incidence and absolute number of severe MAS cases per year decreased (p=0.008 and 0.006, respectively), though the percentage of severe MAS among all neonates with MAS did not change. Risk factors for severe MAS were acute tocolysis (odds ratio 18.2 (95% confidence interval 2.1–155.3), p<0.001) fetal distress (3.4 (1.8–6.4), p<0.001), and severe and moderate birth asphyxia (4.4 (2.0–9.7), p=0.001 and 2.9 (1.5–5.6), p=0.009).

Conclusion:

The incidence and absolute numbers of MAS and severe MAS cases changed during the study period as well as neonatal management. Acute tocolysis, fetal distress, and asphyxia were associated with severe MAS.

Zusammenfassung

Hintergrund:

Ziel dieser Arbeit war es, den Verlauf perinataler Faktoren bei Kindern mit Mekoniumaspirationssyndrom (MAS) im Zeitraum von 1990–2010 darzustellen sowie Risikofaktoren für einen schweren Verlauf zu identifizieren.

Patienten:

Alle Neugeborenen, die an unserer Level-III-Neugeborenenintensivstation von 1990 bis 2010 mit MAS stationär waren.

Methode:

Retrospektive Analyse perinataler Faktoren und Analyse von Risikofaktoren für ein schweres MAS (invasiv mechanische Beatmung ≥ 7 Tage oder Hochfrequenzbeatmung oder extrakorporale Membranoxygenierung).

Ergebnisse:

Von 205 Neugeborenen mit MAS hatten 55 (27%) ein schweres MAS. Die Inzidenz und die absolute Anzahl der MAS-Fälle pro Jahr sank über den Beobachtungszeitraum signifikant (p=0,003 und 0,005), ebenso der Anteil von Kindern mit MAS, die von peripheren Krankenhäusern an unser Zentrum transferiert wurden (p=0,004), die Dauer der invasiven Beatmung (p=0,004) und Hospitalisierung (p=0,036). Die Inzidenz und die absolute Anzahl schwerer MAS-Fälle nahmen über den Beobachtungszeitraum ab (p=0,008 und 0,006), nicht aber der prozentuelle Anteil schwerer Fälle unter allen Kindern mit MAS. Als Risikofaktoren für schweres MAS identifizierten wir die Akuttokolyse (Odds Ratio 18,2 (95% Konfidenzintervall 2,1–155,3), p<0,001) ein pathologisches CTG (3,4 (1,8–6,4), p<0,001), schwere und mittelgradige Asphyxie (4,4 (2,0–9,7) und 2,9 (1,5–5,6), p=0,001 bzw. p=0,009).

Schlussfolgerung:

Die Inzidenz und absolute Anzahl der MAS-Fälle sowie der schweren MAS-Fälle und ihre neonatale Behandlung veränderten sich während der letzten 21 Jahre. Akuttokolyse, ein pathologisches CTG und Asphyxie waren mit einem schweren Krankheitsverlauf assoziiert.

 
  • References

  • 1 Ahanya SN, Lakshmanan J, Morgan BL et al. Meconium passage in utero: mechanisms, consequences, and management. Obstet Gynecol Surv 2005; 60: 45-56
  • 2 Cayabyab RG, Kwong K, Jones C et al. Lung inflammation and pulmonary function in infants with meconium aspiration syndrome. Pediatr Pulmonol 2007; 42: 898-905
  • 3 Cleary GM, Wiswell TE. Meconium-stained amniotic fluid and the meconium aspiration syndrome. An update. Pediatr Clin North Am 1998; 45: 511-529
  • 4 Dargaville PA. Respiratory support in meconium aspiration syndrome: a practical guide. Int J Pediatr 2012; 2012: 965159
  • 5 Dargaville PA, Copnell B. The epidemiology of meconium aspiration syndrome: incidence, risk factors, therapies, and outcome. Pediatrics 2006; 117: 1712-1721
  • 6 Eber E, Zach MS. Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy). Thorax 2001; 56: 317-323
  • 7 Fanaroff AA. Meconium aspiration syndrome: historical aspects. J Perinatol 2008; 28 (Suppl. 03) S3-S7
  • 8 Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723-1729
  • 9 Laughon MM, Langer JC, Bose CL et al. Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants. Am J Respir Crit Care Med 2011; 183: 1715-1722
  • 10 Lin HC, Su BH, Lin TW et al. Risk factors of mortality in meconium aspiration syndrome: review of 314 cases. Acta Paediatr Taiwan 2004; 45: 30-34
  • 11 Lin HC, Su BH, Lin TW et al. System-based strategy for the management of meconium aspiration syndrome: 198 consecutive cases observations. Acta Paediatr Taiwan 2005; 46: 67-71
  • 12 Liu WF, Harrington T. The need for delivery room intubation of thin meconium in the low-risk newborn: a clinical trial. Am J Perinatol 1998; 15: 675-682
  • 13 Manganaro R, Mami C, Palmara A et al. Incidence of meconium aspiration syndrome in term meconium-stained babies managed at birth with selective tracheal intubation. J Perinat Med 2001; 29: 465-468
  • 14 Miltenburg AS, van Elburg RM, Kostense PJ et al. Neonatal morbidity in term neonates is related to gestational age at birth and level of care. J Perinat Med 2011; 39: 605-610
  • 15 Okazaki K, Kondo M, Kato M et al. Serum cytokine and chemokine profiles in neonates with meconium aspiration syndrome. Pediatrics 2008; 121: e748-e753
  • 16 Oyelese Y, Culin A, Ananth CV et al. Meconium-stained amniotic fluid across gestation and neonatal acid-base status. Obstet Gynecol 2006; 108: 345-349
  • 17 Phibbs CS, Baker LC, Caughey AB et al. Level and volume of neonatal intensive care and mortality in very-low-birth-weight infants. N Engl J Med 2007; 356: 2165-2175
  • 18 Rosegger H, Rosanelli K, Hofmann H et al. Meconium stained amniotic fluid: obstetric and pediatric management to prevent meconium aspiration syndrome. Klin Padiatr 1982; 194: 381-386
  • 19 Rossi EM, Philipson EH, Williams TG et al. Meconium aspiration syndrome: intrapartum and neonatal attributes. Am J Obstet Gynecol 1989; 161: 1106-1110
  • 20 Schaible T, Hermle D, Loersch F et al. A 20-year experience on neonatal extracorporeal membrane oxygenation in a referral center. Intensive Care Med 2010; 36: 1229-1234
  • 21 Schaible T, Veit M, Tautz J et al. Serum cytokine levels in neonates with congenital diaphragmatic hernia. Klin Padiatr 2011; 223: 414-418
  • 22 Schmölzer G, Urlesberger B, Reiterer F et al. Inhalation therapy with nitric oxide in pulmonary hypertension: Comparison of preterm infants versus newborn infants. Klin Padiatr 2003; 215: 257-261
  • 23 Singh BS, Clark RH, Powers RJ et al. Meconium aspiration syndrome remains a significant problem in the NICU: outcomes and treatment patterns in term neonates admitted for intensive care during a ten-year period. J Perinatol 2009; 29: 497-503
  • 24 Vain NE, Szyld EG, Prudent LM et al. What (not) to do at and after delivery? Prevention and management of meconium aspiration syndrome. Early Hum Dev 2009; 85: 621-626
  • 25 Wiswell TE, Gannon CM, Jacob J et al. Delivery room management of the apparently vigorous meconium-stained neonate: results of the multicenter, international collaborative trial. Pediatrics 2000; 105: 1-7
  • 26 Wiswell TE, Tuggle JM, Turner BS. Meconium aspiration syndrome: have we made a difference?. Pediatrics 1990; 85: 715-721
  • 27 Wu YW, Backstrand KH, Zhao S et al. Declining diagnosis of birth asphyxia in California: 1991–2000. Pediatrics 2004; 114: 1584-1590
  • 28 Xu H, Calvet M, Wei S et al. Risk factors for early and late onset of respiratory symptoms in babies born through meconium. Am J Perinatol 2010; 27: 271-278
  • 29 Yeast JD, Poskin M, Stockbauer JW et al. Changing patterns in regionalization of perinatal care and the impact on neonatal mortality. Am J Obstet Gynecol 1998; 178: 131-135
  • 30 Yoder BA, Kirsch EA, Barth WH et al. Changing obstetric practices associated with decreasing incidence of meconium aspiration syndrome. Obstet Gynecol 2002; 99: 731-739
  • 31 Zhang X, Kramer MS. Variations in mortality and morbidity by gestational age among infants born at term. J Pediatr 2009; 154: 358-362 362 e351